Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-06

Clinical Trial Update: Study of AHIST in Seasonal Allergic Rhinitis Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating AHIST for seasonal allergic rhinitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AHIST

Snippet

Sponsor: Magna Pharmaceuticals, Inc. | Conditions: Rhinitis, Allergic, Seasonal | Phase 1 | Status: WITHDRAWN